chitosan has been researched along with Colitis, Ulcerative in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.56) | 18.2507 |
| 2000's | 2 (5.13) | 29.6817 |
| 2010's | 12 (30.77) | 24.3611 |
| 2020's | 24 (61.54) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Fu, Z; Huo, J; Ju, J; Lv, J; Niu, W; Wang, L; Zhang, Z | 1 |
| Chen, K; He, N; Jin, M; Jung, S; Lee, MS; Li, S; Vu, SH; Zhang, H; Zheng, Z | 1 |
| Chen, S; Fang, W; Gao, S; Hu, R; Lu, W; Nie, X; Sun, L; Zhang, Q | 1 |
| Fan, Y; Jiang, Z; Liu, T; Liu, Z; Peng, N; Zhang, Z | 1 |
| Choudhury, SR; Guchhait, P; Gupta, S; Karmakar, S; Mohanbhai, SJ; Sardoiwala, MN; Sharma, SS; Shrimali, N | 1 |
| Abdelhamid, AM; Amin, NA; Cavalu, S; El-Ahwany, E; El-Azez, RA; El-Rafi, AA; El-Sandarosy, R; Elagamy, HI; Essam, M; Essam, N; Gaafar, AGA; Girgis, S; Hasaballah, A; Kamal, I; Mahmoud, F; Mansour, M; Mohamed, D; Mohammed, OA; Nasr, M; Rizk, H; Saber, S; Youssef, ME | 1 |
| Chen, H; Dong, Z; Li, N; Li, Y; Wang, J; Wu, C; Zhang, M; Zhang, Y; Zheng, T; Zou, P | 1 |
| Lin, L; Miao, WH; Peng, SJ; Song, Y; Wen, ZS; Xue, YR; Ye, DT; Zhao, YD; Zheng, B; Zheng, J | 1 |
| Fu, Y; Wang, S; Xie, Y; Xiong, H; Xue, G | 1 |
| Chen, J; He, B; Li, J; Li, S; Pu, Y | 1 |
| Doostan, M; Farzaei, MH; Maleki, H; Miraghaee, S; Seifi, P | 1 |
| Deng, S; Dong, Y; Guan, Z; Guo, Z; He, B; Lei, H; Leng, X; Ma, R; Wang, D; Xing, J; You, C; Yu, J; Zhang, Y; Zhou, Q | 1 |
| Bitaraf, FS; Hassani, MS; Mahami, S; Mehrabi, M; Omri, A; Salehi, M; Vahedi, H | 1 |
| Adhikari, A; Ahmed, ASA; Ahmed, SA; Al-Rooqi, MM; Bhattacharya, SS; Bhattacharyya, D; Darbar, S; Das, M; Ghosh, R; Kumar Das, A; Mallick, AK; Mondal, S; Moussa, Z; Pal, D; Pal, SK; Singh, M | 1 |
| Chen, Y; Fang, P; Hao, S; He, H; Hu, H; Li, Y; Xiong, M; Xu, M; Yu, S | 1 |
| Ding, H; Du, Q; Ping, H; Wang, K; Wu, M; Yang, Z; Zhang, M | 1 |
| Guo, C; Li, X; Wang, J; Zhang, C | 1 |
| He, C; Liu, Y; Song, Y; Tang, C; Xu, L; Yin, C; Yue, H | 1 |
| Chen, SQ; Hu, FQ; Lou, HY; Song, YQ; Tao, S; Wang, C; Yu, FY; Yuan, H | 1 |
| Dua, K; Gandhi, H; Negi, P; Rathore, C; Tambuwala, MM; Vihal, S | 1 |
| Li, X; Liu, Y; Wang, X; Xiao, B; Zhou, X | 1 |
| Hattori, Y; Ikeuchi-Takahashi, Y; Onishi, H; Zhou, H | 1 |
| Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y | 1 |
| Cao, X; Chen, S; Duan, L; Guo, Z; Han, Z; Han, ZC; Hou, H; Li, Z; Liu, N; Liu, Y; Qi, X; Wang, C; Zhang, D; Zhang, S; Zhao, Q | 1 |
| Dushkin, AV; Jin, K; Polyakov, NE; Pu, F; Su, W; Xie, Z; Xu, W; Xue, Z | 1 |
| Pande, S; Solanki, A; Vashi, J | 1 |
| Elsabahy, M; Helmy, AM; Ibrahim, EA; Mahmoud, MA; Soliman, GM | 1 |
| Han, MK; Liu, D; Merlin, D; Wang, L; Xu, C; Zhang, M | 1 |
| Gui, S; Guo, J; Huang, Y | 1 |
| Fischer, D; Lautenschläger, C; Lehr, CM; Schmidt, C; Stallmach, A | 1 |
| Cui, YL; Gao, LN; Wang, GF; Wang, QS; Zhou, J | 1 |
| Barralet, J; Cerruti, M; Lerouge, S; Samaei, S; Stevenson, MM; Tam, M; Xu, J | 1 |
| Han, MK; Kang, Y; Merlin, D; Viennois, E; Xiao, B; Xu, Z; Zhang, M; Zhang, Y; Zhang, Z | 1 |
| Dubey, R; Jain, SK; Omrey, P; Vyas, SP | 1 |
| Cao, Q; Cui, J; Yang, S; Zhu, Y | 1 |
| Chen, C; Chen, J; Gao, C; Lii, S; Liu, M | 1 |
| Yamamoto, A | 1 |
| Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Suzuki, T; Tanaka, C; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
| Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Okada, N; Suzuki, T; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
3 review(s) available for chitosan and Colitis, Ulcerative
| Article | Year |
|---|---|
Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges.
Topics: Administration, Oral; Alginates; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Pharmaceutical Preparations | 2022 |
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
[Study on the colon specific delivery of prednisolone using chitosan capsules].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Capsules; Chitosan; Colitis, Ulcerative; Colon; Drug Delivery Systems; Gelatin; Humans; Intestinal Mucosa; Prednisolone; Rats | 2007 |
2 trial(s) available for chitosan and Colitis, Ulcerative
| Article | Year |
|---|---|
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Topics: Administration, Oral; Adult; Case-Control Studies; Chitosan; Colitis, Ulcerative; Crohn Disease; Drug Carriers; Drug Delivery Systems; Female; Humans; Intestinal Mucosa; Lactic Acid; Male; Microspheres; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2013 |
35 other study(ies) available for chitosan and Colitis, Ulcerative
| Article | Year |
|---|---|
Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Chitosan; Colitis, Ulcerative; Cytokines; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred ICR; Molecular Weight; RAW 264.7 Cells | 2021 |
Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Topics: Administration, Oral; Alginates; Berberine; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Delivery Systems; Humans; Inflammation; Mucus; Nanoparticles | 2022 |
Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice.
Topics: Animals; Bacillus coagulans; Chitosan; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Interleukin-4; Mice; Oligosaccharides | 2022 |
Colon targeted chitosan-melatonin nanotherapy for preclinical Inflammatory Bowel Disease.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Colitis, Ulcerative; Inflammatory Bowel Diseases; Melatonin; Mice | 2022 |
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis.
Topics: Acetic Acid; AMP-Activated Protein Kinases; Animals; Canagliflozin; Chitosan; Colitis; Colitis, Ulcerative; Colon; Cytokines; Hyaluronic Acid; Microspheres; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Signal Transduction | 2022 |
Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota.
Topics: Animals; Berberine; Chitosan; Claudin-2; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Eosine Yellowish-(YS); Excipients; Gastrointestinal Microbiome; Hematoxylin; Humans; Hypromellose Derivatives; Interleukin-6; Mice; Mice, Inbred C57BL; Occludin; Pectins; RNA, Ribosomal, 16S | 2022 |
Synthesis, Characterization of Low Molecular Weight Chitosan Selenium Nanoparticles and Its Effect on DSS-Induced Ulcerative Colitis in Mice.
Topics: Animals; Chitosan; Colitis, Ulcerative; Mice; Molecular Weight; Nanoparticles; Selenium | 2022 |
Eudragit-coated chitosan-tripterygium glycoside conjugate microspheres alleviate DSS-induced experimental colitis by inhibiting the TLR4/NF-κB signaling pathway.
Topics: Animals; Cardiac Glycosides; Chitosan; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Glycosides; Mice; Microspheres; NF-kappa B; Renal Dialysis; Signal Transduction; Toll-Like Receptor 4; Tripterygium | 2023 |
Orally Administrated Olsalazine-Loaded Multilayer Pectin/Chitosan/Alginate Composite Microspheres for Ulcerative Colitis Treatment.
Topics: Alginates; Chitosan; Colitis, Ulcerative; Humans; Microspheres; Pectins | 2023 |
Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
Topics: Achillea; Animals; Chitosan; Colitis; Colitis, Ulcerative; Colon; Inflammation; Nanoparticles; Rats | 2023 |
Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment.
Topics: Chitosan; Colitis; Colitis, Ulcerative; Colon; Drug Delivery Systems; Humans; Hyaluronic Acid; Macrophages; Nanoparticles | 2023 |
pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Topics: Animals; Berberine; Chitosan; Colitis, Ulcerative; Hydrogen-Ion Concentration; Mesalamine; Nanoparticles; Rats | 2023 |
Chitosan functionalized Mn
Topics: Animals; Chitosan; Colitis, Ulcerative; Mice; Nanoparticles; Oxidation-Reduction; Reactive Oxygen Species | 2023 |
Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
Topics: Animals; Chitosan; Colitis, Ulcerative; Cyclosporine; Dextran Sulfate; Mice; Nanoparticles; Polymers | 2023 |
Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
Topics: Animals; Chitosan; Colitis, Ulcerative; Colon; Curcumin; Cyclooxygenase Inhibitors; Folic Acid; Hydrogels; Liposomes; Macrophages; Mice; Nanoparticles; Pectins | 2023 |
Chitosan Ameliorates DSS-Induced Ulcerative Colitis Mice by Enhancing Intestinal Barrier Function and Improving Microflora.
Topics: Animals; Blotting, Western; Chitosan; Colitis, Ulcerative; Dextran Sulfate; Gastrointestinal Microbiome; Male; Mice; Tight Junction Proteins | 2019 |
siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
Topics: Administration, Oral; Animals; Chitosan; Colitis, Ulcerative; Cysteine; Inflammation; Kinetics; Liver; Macrophages; Male; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Polymers; RAW 264.7 Cells; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2020 |
Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Caco-2 Cells; Caprylates; Chitosan; Colitis, Ulcerative; Colon; Cross-Linking Reagents; Cytokines; Dexamethasone; Drug Carriers; Esterases; Humans; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Nitric Oxide; Quercetin; RAW 264.7 Cells; Stimuli Responsive Polymers | 2020 |
Efficacy of resveratrol encapsulated microsponges delivered by pectin based matrix tablets in rats with acetic acid-induced ulcerative colitis.
Topics: Acetic Acid; Animals; Antioxidants; Chemistry, Pharmaceutical; Chitosan; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Particle Size; Pectins; Rats; Rats, Wistar; Resveratrol; Tablets | 2020 |
Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Chitosan; Colitis, Ulcerative; Curcumin; Drug Carriers; Drug Liberation; Hydrogels; Interleukin-6; Macrophages; Mice; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Phagocytosis; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; Tumor Necrosis Factor-alpha; X-Ray Diffraction | 2020 |
Nanogels of a Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Release Behavior, Gastrointestinal Distribution, and Systemic Absorption.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Delivery Systems; Gastrointestinal Absorption; Gastrointestinal Tract; Gels; Male; Prednisolone; Rats, Wistar; Succinic Acid | 2020 |
IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE
Topics: Animals; Cells, Cultured; Chitosan; Colitis, Ulcerative; Colon; Dinoprostone; Disease Models, Animal; Drug Carriers; Female; Humans; Hydrogels; Insulin-Like Growth Factor I; Intestinal Mucosa; Macrophage Activation; Macrophages, Peritoneal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Placenta; Pregnancy; Primary Cell Culture; Trinitrobenzenesulfonic Acid | 2020 |
Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.
Topics: Administration, Oral; Alginates; Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Hydrogels; Hydrogen-Ion Concentration; Intestinal Mucosa; Male; Mesalamine; Mice; Particle Size; Rats | 2021 |
QbD-Enabled Systematic Development of Ileo-Colonic Targeted Novel Mucoadhesive Microspheres of Flurbiprofen.
Topics: Chitosan; Colitis, Ulcerative; Drug Delivery Systems; Flurbiprofen; Humans; Microspheres; Particle Size; Polymethacrylic Acids; Spectroscopy, Fourier Transform Infrared | 2022 |
Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease.
Topics: Acetic Acid; Animals; Azathioprine; Catalase; Chitosan; Colitis, Ulcerative; Colon; Drug Carriers; Drug Liberation; Immunosuppressive Agents; Male; Rabbits; Superoxide Dismutase | 2017 |
Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
Topics: Alginates; Animals; Biocompatible Materials; Catechols; Cell Line; Chitosan; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Epithelial Cells; Folic Acid; Glucuronic Acid; Heme Oxygenase-1; Hexuronic Acids; Hydrogels; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Macrophages; Membrane Proteins; Mice; Nanoparticles; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Polyethylene Glycols; RNA, Messenger; Tumor Necrosis Factor-alpha; Wound Healing | 2018 |
Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Topics: Animals; Chitosan; Colitis, Ulcerative; Galactose; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2018 |
Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Topics: Alginates; Animals; Biological Availability; Chitosan; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Flavonoids; Glucuronic Acid; Hexuronic Acids; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Microspheres; Rats; Rats, Sprague-Dawley; Solubility; Trinitrobenzenesulfonic Acid | 2016 |
Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
Topics: Adhesives; Animals; Body Weight; Catechols; Chitosan; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Drug Delivery Systems; Hydrogels; Mice; Mucins; Occult Blood; Rectum; Sulfasalazine; Tumor Necrosis Factor-alpha | 2017 |
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Compounding; Epithelial Cells; Gene Expression; Glucuronic Acid; Hexuronic Acids; Humans; Hyaluronic Acid; Hydrogels; Macrophages; Male; Melanocyte-Stimulating Hormones; Mice; Molecular Targeted Therapy; Nanoparticles; Particle Size; Peptide Fragments; RAW 264.7 Cells; Sodium Dodecyl Sulfate; Static Electricity; Tumor Necrosis Factor-alpha | 2017 |
Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chitosan; Colitis, Ulcerative; Colon; Drug Carriers; Drug Combinations; Drug Compounding; Drug Delivery Systems; Excipients; Female; Glycine; Male; Mesalamine; Microspheres; Particle Size; Polymethacrylic Acids; Rats; Rats, Mutant Strains; Solubility | 2010 |
[Preparation and pharmacodynamic evaluation of diammonium glycyrrhizinate-loaded chitosan nanoparticles].
Topics: Animals; Chitosan; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Female; Glycyrrhizic Acid; Male; Mice; Nanoparticles | 2010 |
In vitro degradation and drug-release properties of water-soluble chitosan cross-linked oxidized sodium alginate core-shell microgels.
Topics: Administration, Oral; Alginates; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cell Death; Chitosan; Colitis, Ulcerative; Colon; Drug Delivery Systems; Drug Liberation; Electrolytes; Gels; Glucuronic Acid; HEK293 Cells; Hexuronic Acids; Humans; Hydrodynamics; Mesalamine; Oxidation-Reduction; Solutions; Temperature; Water | 2012 |
Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
Topics: Animals; Capsules; Chitin; Chitosan; Colitis, Ulcerative; Colon; Male; Pentanoic Acids; Peroxidase; Pyridines; Rats; Rats, Wistar; Thromboxane-A Synthase; Trinitrobenzenesulfonic Acid | 1999 |
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Carboxymethylcellulose Sodium; Chitin; Chitosan; Colitis, Ulcerative; Colon; Drug Carriers; Intestinal Absorption; Male; Mesalamine; Peroxidase; Rats; Rats, Wistar; Tissue Distribution; Trinitrobenzenesulfonic Acid | 2002 |